)
)
Aptinyx Investor Relations Material
Latest events
Q3 2022
Aptinyx
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Aptinyx Inc
Access all reports
Aptinyx Inc. is a biopharmaceutical company focused on developing therapies for neurological disorders. The company leverages its expertise in small-molecule compounds that modulate NMDA receptors to address conditions such as chronic pain, post-traumatic stress disorder, and cognitive impairment. Aptinyx’s research and development efforts aim to create innovative treatments for patients with unmet medical needs. The company is headquartered in Evanston, Illinois, and its shares are listed on the NASDAQ.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
APTX
Country
🇺🇸 United States